Device and diagnostic manufacturers located outside the UK must appoint a UK Responsible Person (UKRP) as soon as possible from 1 January 2021. That requirement is contained in new guidance from the UK Medicines and Healthcare products Regulatory Agency (MHRA), issued on 8 December.
The guidance also states that the agency will only accept the registration of devices from manufacturers or UKRPs that have a place of business in the UK, or from...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?